Search results
Stéphane Bancel (born July 20, 1972) is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux.
Meet our executive team. Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of Moderna’s board of directors since March 2011. Before joining the Company, Mr. Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMérieux SA.
5 days ago · About Stéphane Bancel. Stephane Bancel is the CEO of Cambridge, Massachusetts-based biotech firm Moderna, known for its Covid-19 vaccine. He became CEO of Moderna in 2011 and owns a roughly...
Aug 27, 2021 · Stéphane Bancel: Simply put, messenger RNA [mRNA] vaccines are a new type of medicine that trigger an immune response to protect against infectious diseases. Many other vaccines put a weakened or inactivated virus into the body to trigger that response.
Feb 7, 2024 · February 7, 2024. CAMBRIDGE, MA / ACCESSWIRE / February 7, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that Stéphane Bancel, Chief Executive Officer, has been elected to the National Academy of Engineering (NAE), broadly known as one of the highest acknowledgments of achievement in the field, in recognition of distinguished ...
Apr 26, 2023 · Moderna’s CEO shares what it was like to leap from pre-revenue startup to household name and Fortune 500 company. BY Fortune Editors. April 26, 2023, 4:00 PM PDT. Modern CEO Stephane Bancel ...
Moderna CEO Stéphane Bancel did not have the immense resources of Pfizer immediately on hand when COVID hit, but he had realized the pandemic’s imminent threat in late 2019, even while the virus was still thought to be contained in China.
Related searches
